Structure Embedded Nucleus Classification for Histopathology Images

Apr 12, 2024·
Wei Lou
1st Author
,
Xiang Wan
,
Guanbin Li
,
Xiaoying Lou
Cheng-Hang LI
Cheng-Hang LI
Feng GAO
Feng GAO
,
Haofeng Li
Corresponding Author
· 0 min read
Abstract
Nuclei classification provides valuable information for histopathology image analysis. However, the large variations in the appearance of different nuclei types cause difficulties in identifying nuclei. Most neural network based methods are affected by the local receptive field of convolutions, and pay less attention to the spatial distribution of nuclei or the irregular contour shape of a nucleus. In this paper, we first propose a novel polygon-structure feature learning mechanism that transforms a nucleus contour into a sequence of points sampled in order, and employ a recurrent neural network that aggregates the sequential change in distance between key points to obtain learnable shape features. Next, we convert a histopathology image into a graph structure with nuclei as nodes, and build a graph neural network to embed the spatial distribution of nuclei into their representations. To capture the correlations between the categories of nuclei and their surrounding tissue patterns, we further introduce edge features that are defined as the background textures between adjacent nuclei. Lastly, we integrate both polygon and graph structure learning mechanisms into a whole framework that can extract intra and inter-nucleus structural characteristics for nuclei classification. Experimental results show that the proposed framework achieves significant improvements compared to the previous methods. Code and data are made available via https://github.com/lhaof/SENC.
Type
Publication
IEEE Transactions on Medical Imaging
publication
Cheng-Hang LI
Authors
Research Assistant
I am a research assistant focusing on deep learning, multimodal feature fusion, and medical AI system development.
Feng GAO
Authors
Professor
My research leverages AI and big data to improve diagnostics, prognostics, and ultimately, outcomes in cancer and other biomedical fields.